Prostate Cancer News and Research

RSS
Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.

Further Reading

Study reveals how aggressive prostate cancer metastasizes by evading the immune system

Study reveals how aggressive prostate cancer metastasizes by evading the immune system

Mathematical model helps quantify metastatic cell behavior

Mathematical model helps quantify metastatic cell behavior

AI-enabled device detects if targeted chemotherapy is working

AI-enabled device detects if targeted chemotherapy is working

New research uncovers mechanism behind the newest generation of cancer drugs

New research uncovers mechanism behind the newest generation of cancer drugs

Could hormone therapy for prostate cancer increase the risk of Alzheimer’s disease?

Could hormone therapy for prostate cancer increase the risk of Alzheimer’s disease?

Adequate consumption of milk and dairy products can help prevent chronic diseases

Adequate consumption of milk and dairy products can help prevent chronic diseases

Research reveals key cellular mechanism leading to aggressive prostate cancer

Research reveals key cellular mechanism leading to aggressive prostate cancer

Perspectives on how to communicate to older adults about stopping cancer screening

Perspectives on how to communicate to older adults about stopping cancer screening

Hypofractionated proton therapy for prostate cancer can be just as effective as standard treatment

Hypofractionated proton therapy for prostate cancer can be just as effective as standard treatment

New biomarker in urine can help detect aggressive prostate cancer

New biomarker in urine can help detect aggressive prostate cancer

Study finds new cancer driver which is fast, furious and loud

Study finds new cancer driver which is fast, furious and loud

Researchers use genetically manipulated virus to combat prostate cancer

Researchers use genetically manipulated virus to combat prostate cancer

Heat from nanoparticles zaps cancer cells from inside

Heat from nanoparticles zaps cancer cells from inside

New prostate cancer test could bring an end to unnecessary biopsies

New prostate cancer test could bring an end to unnecessary biopsies

Novel combination therapy shown to be safe and effective for prostate cancer patients

Novel combination therapy shown to be safe and effective for prostate cancer patients

New class of radiopharmaceuticals offer fresh perspective on cancer imaging, theranostics

New class of radiopharmaceuticals offer fresh perspective on cancer imaging, theranostics

Interim scan during therapy helps guide prostate cancer treatment, shows research

Interim scan during therapy helps guide prostate cancer treatment, shows research

New chemoimmunotherapy regimen for aggressive form of lymphoma gets FDA approval

New chemoimmunotherapy regimen for aggressive form of lymphoma gets FDA approval

Study reveals link between WTC dust and prostate cancer

Study reveals link between WTC dust and prostate cancer

New probe can identify and latch onto proteins on surface of endoplasmic reticulum

New probe can identify and latch onto proteins on surface of endoplasmic reticulum